ENZON PHARM INC ENZN (NASDAQ)

$ 7.44
16:10
Change: +0.08 (+1.09%)
Volume: 155,700

Avg. Volume: 422870
P/E Ratio: 5.8
EPS (Annual): 1.23
Profit Margin:
Dividend & Yield(Annual): .0%
Shares Outstanding: 44,659
Institutional Shareholders: NA
Last: 7.44
Change: +0.08 (+1.09%)
Prev. Close: 7.36
Open: 7.35
Day's Range: 7.28 - 7.50
52wk Range: 6.31 - 10.36
Market Value: 318,499
Beta: 1.57
12-month EPS Change: 2360.0%
Total Return Last 12 Months: -9.3%
Total Return Last 3 Years: 9.9%
Total Return Last 5 Years: -43.3%
5-Year Revenue Growth Rate: 1.74%
5-Year Dividend Growth Rate: NC
5-Year EPS Growth Rate: NC


Headlines on ENZN
Alert me Subscribe

Investor urges Enzon to consider sale of entire company

(NEW YORK)A shareholder of Enzon Pharmaceuticals Inc. has urged the drug maker to explore its strategic alternatives, including a sale of the entire company, according to a Securities and Ex...READ MORE
May 20, 2008 12:04PM
Keywords: ENZN

ImClone Names Kenneth Zuerblis As CFO

(NEW YORK)ImClone Systems Inc. said Monday it has appointed Kenneth Zuerblis as chief financial officer and senior vice president. Zuerblis, 49, was CFO of Enzon Pharmaceuticals Inc. for 11 ...READ MORE
Mar 31, 2008 7:34AM
Keywords: IMCL, ENZN

Carl Icahn Urges Enzon to Consider Sale

(NEW YORK)A group of funds controlled by billionaire investor Carl Icahn have acquired a 6.9 percent interest in Enzon Pharmaceuticals Inc. and urged the drug maker to consider selling the c...READ MORE
Mar 14, 2008 2:18PM
Keywords: ENZN

Enzon Cuts Debt to $12.5 Million

(BRIDGEWATER, N.J.)Drug maker Enzon Pharmaceuticals Inc. said Thursday it cut its debt "significantly" to $12.5 million after selling future royalty rights for drug development technology.READ MORE
Feb 14, 2008 11:28AM
Keywords: ENZN

Holder Drops Enzon Board Nominations

(NEW YORK)DellaCamera Capital Master Fund Ltd. said Tuesday it has agreed to withdraw its three nominations to the board of drug maker Enzon Pharmaceuticals Inc., according to a filing with ...READ MORE
Feb 12, 2008 2:44PM
Keywords: ENZN

Carl Icahn Urges Enzon to Consider Sale

(NEW YORK)A group of funds controlled by billionaire investor Carl Icahn have acquired a 6.9 percent interest in Enzon Pharmaceuticals Inc. and urged the drug maker to consider selling the c...READ MORE
Mar 14, 2008 2:18PM
Keywords: ENZN

Enzon Cuts Debt to $12.5 Million

(BRIDGEWATER, N.J.)Drug maker Enzon Pharmaceuticals Inc. said Thursday it cut its debt "significantly" to $12.5 million after selling future royalty rights for drug development technology.READ MORE
Feb 14, 2008 11:28AM
Keywords: ENZN
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN -1.00 50.84
GILEAD SCIENCES +28.30 51.09
THIRD WAVE TECH +64.50 11.19
CELGENE CP +19.70 67.37
INVITROGEN CORP -5.70 38.41